Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:43 pm Sale |
2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA |
EcoR1 Capital, LLC | 3,223,851 2.900% |
-2,394,928 (-42.62%) |
Filing History |
| 2024-10-08 4:35 pm Purchase |
2024-10-06 | 13D | Galapagos NV GLPG |
EcoR1 Capital, LLC | 7,094,049 10.770% |
588,159 (+9.04%) |
Filing History |
| 2024-09-03 5:51 pm Purchase |
2024-08-23 | 13G | Whitehawk Therapeutics Inc WHWK |
EcoR1 Capital, LLC | 1,845,253 7.500% |
1,845,253 (New Position) |
Filing History |
| 2024-08-23 4:01 pm Unchanged |
2024-08-19 | 13D | Galapagos NV GLPG |
EcoR1 Capital, LLC | 6,505,890 9.900% |
0 (Unchanged) |
Filing History |
| 2024-08-16 12:07 pm Purchase |
2024-08-14 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital, LLC | 7,794,996 25.800% |
274,572 (+3.65%) |
Filing History |
| 2024-07-01 4:39 pm Purchase |
2024-06-20 | 13G | Tectonic Therapeutic, Inc. TECX |
EcoR1 Capital, LLC | 849,143 5.800% |
849,143 (New Position) |
Filing History |
| 2024-05-31 5:25 pm Purchase |
2024-05-22 | 13G | HOOKIPA Pharma Inc. HOOK |
EcoR1 Capital, LLC | 571,732 5.900% |
112,230 (+24.42%) |
Filing History |
| 2024-05-03 5:02 pm Purchase |
2024-04-23 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital, LLC | 3,014,752 6.000% |
2,803,490 (+1327.02%) |
Filing History |
| 2024-04-08 2:46 pm Purchase |
2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ |
EcoR1 Capital, LLC | 1,219,774 4.800% |
1,219,774 (New Position) |
Filing History |
| 2024-03-26 11:59 am Purchase |
2024-03-08 | 13G | Adaptimmune Therapeutics plc ADAP |
EcoR1 Capital, LLC | 164,424,420 10.700% |
51,000,000 (+44.96%) |
Filing History |
| 2024-03-11 3:34 pm Purchase |
2024-02-28 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
EcoR1 Capital, LLC | 4,155,375 5.300% |
4,155,375 (New Position) |
Filing History |
| 2024-02-22 7:01 pm Unchanged |
2024-02-22 | 13D | Zymeworks Inc. ZYME |
EcoR1 Capital, LLC | 14,132,291 19.990% |
0 (Unchanged) |
Filing History |
| 2024-02-16 12:54 pm Purchase |
2024-02-05 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital, LLC | 1,944,672 5.400% |
1,944,672 (New Position) |
Filing History |
| 2024-02-15 11:38 am Unchanged |
2023-12-31 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital, LLC | 211,262 0.400% |
0 (Unchanged) |
Filing History |
| 2024-02-15 11:35 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital, LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing History |
| 2024-02-15 09:15 am Unchanged |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital, LLC | 6,995,861 8.400% |
0 (Unchanged) |
Filing History |
| 2024-02-14 8:02 pm Purchase |
2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital, LLC | 6,995,861 8.400% |
811,000 (+13.11%) |
Filing History |
| 2024-02-14 7:54 pm Sale |
2023-12-31 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital, LLC | 211,262 0.400% |
-3,740,304 (-94.65%) |
Filing History |
| 2024-02-14 6:59 pm Purchase |
2023-12-31 | 13G | Zymeworks Inc. ZYME |
EcoR1 Capital, LLC | 14,132,291 19.990% |
694,818 (+5.17%) |
Filing History |
| 2024-02-14 6:54 pm Unchanged |
2023-12-31 | 13G | Xencor, Inc. XNCR |
EcoR1 Capital, LLC | 5,282,516 8.700% |
0 (Unchanged) |
Filing History |